2020
DOI: 10.1016/j.cell.2020.10.021
|View full text |Cite
|
Sign up to set email alerts
|

Coordinated Cellular Neighborhoods Orchestrate Antitumoral Immunity at the Colorectal Cancer Invasive Front

Abstract: During preparation of our article, Shigemi Kinoshita was inadvertently omitted as an author. The author list and Author Contributions section of the online article have been updated. All co-authors have approved the changes. We apologize for the omission.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
64
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 65 publications
(64 citation statements)
references
References 0 publications
0
64
0
Order By: Relevance
“…The TLS-50 high-scoring regions were confirmed as the TLSs by pathologists based on histopathological features (see Materials and Methods for details). Immunohistochemistry and CODEX ( 47 ) confirmed that the selected genes in TLS-50 ( CD52 , CD53 , HLA-DQB1 , and HLA-DQA1 ) were highly expressed in TLSs in additional patients with HCC. Because of the existence of TLSs in both adjacent normal and tumor regions, the TLS-50 signature could be applied with TCGA data, and we found that HCC with a tumor size of >3 cm or BCLC stage B/C has lower TLS-50 scores, which is in accordance with previous reports that the existence of TLSs in HCC tumor area favors the prognosis ( 45 ).…”
Section: Discussionmentioning
confidence: 83%
See 1 more Smart Citation
“…The TLS-50 high-scoring regions were confirmed as the TLSs by pathologists based on histopathological features (see Materials and Methods for details). Immunohistochemistry and CODEX ( 47 ) confirmed that the selected genes in TLS-50 ( CD52 , CD53 , HLA-DQB1 , and HLA-DQA1 ) were highly expressed in TLSs in additional patients with HCC. Because of the existence of TLSs in both adjacent normal and tumor regions, the TLS-50 signature could be applied with TCGA data, and we found that HCC with a tumor size of >3 cm or BCLC stage B/C has lower TLS-50 scores, which is in accordance with previous reports that the existence of TLSs in HCC tumor area favors the prognosis ( 45 ).…”
Section: Discussionmentioning
confidence: 83%
“…S11, A and B) ( 45 , 46 ). In addition, we found high expression of CD52 (ranked in the top five of the TLS-50), CD53 (ranked sixth from the bottom of the TLS-50), and HLA-DR (the major histocompatibility complex, class II, DR) ( HLA-DQB1 and HLA-DQA1 are ranked the 42nd and 50th in the TLS-50 signature, respectively) in TLS regions by immunohistochemistry ( 47 ) on HCC tissue microarrays (fig. S12, A and B), which also confirmed that the TLS-50 signature was accurate.…”
Section: Resultsmentioning
confidence: 92%
“…The immune tumor microenvironment could affect the survival of cancer patients [ 17 ]. ECM is a key component of the microenvironment around the cells, playing important roles during embryonic development and organ homeostasis.…”
Section: Discussionmentioning
confidence: 99%
“…Transition element isotopes chelated to antibodies as used in mass spectrometric readouts are confined to about 40 unique labels 3 . Antibody-oligonucleotide conjugates used for cyclic immunofluorescence analysis need to be carefully selected, limiting these technologies to roughly 60 analytes 9 .…”
Section: Introductionmentioning
confidence: 99%